Centre for Policy on Ageing
 

 
Can chronic neuroleptic treatment promote sleep disturbances in elderly schizophrenic patients?
Author(s)Jürgen Staedt, Dagrun Dewes, Peter Danos
Journal titleInternational Journal of Geriatric Psychiatry, vol 15, no 2, February 2000
Pagespp 170-176
KeywordsDrugs ; Sleep disorders ; Schizophrenia ; Germany.
AnnotationIt has been proposed that sleep disturbances, especially reduced delta sleep, are related to a poor outcome in schizophrenia. To determine whether long-term treatment with neuroleptics can promote sleep disturbances by increasing the risk of a nocturnal myoclonus syndrome (NMS) (= periodic movements in sleep) related insomnia, the authors of this German study performed all-night polysomnography in 10 chronically ill schizophrenic patients who had been under neuroleptic therapy for a mean of 27 years. NMS-related insomnia was detected in all 10 patients. Potential pathophysiological relationships between long-term neuroleptic therapy and NMS occurrence are discussed. The findings suggests that long-term administration of neuroleptics favours the appearance of insomnia. (RH).
Accession NumberCPA-000502012 A
ClassmarkLLD: CTS: ELK: 767

Data © Centre for Policy on Ageing
...from the Ageinfo database published by Centre for Policy on Ageing.
 
CPA home >> Ageinfo Database >> Last modified: Fri 21 Sep 2018, © CPA 2018 Queries to: webmaster@cpa.org.uk